Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer

  • Authors:
    • Katarzyna Nowinska
    • Magdalena Chmielewska
    • Aleksandra Piotrowska
    • Bartosz Pula
    • Wojciech Pastuszewski
    • Tomasz Krecicki
    • Marzena Podhorska-Okołow
    • Maciej Zabel
    • Piotr Dziegiel
  • View Affiliations

  • Published online on: November 27, 2015     https://doi.org/10.3892/ijo.2015.3273
  • Pages: 635-645
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MCM2, MCM3 and MCM7 are minichromosome maintenance proteins found in dividing cells and they play a role in DNA synthesis. Increased MCM expression level is observed in cells of different cancer types. Additionally, metallothioneins (MT-I/II) are involved in control of cell proliferation and differentiation and changes of their expression are observed in many types of cancer. Ki-67 is known cancer cell proliferation antigen currently used in prognostic evaluation. The study material consisted of 83 laryngeal squamous cell cancer (LSCC) cases and 10 benign hypertrophic lesions of larynx epithelium as a control group. For the present study, laryngeal cancer cell line HEp-2 and human keratinocytes were employed, and to evaluate expression of all the markers, immunohistochemical method (IHC), immunofluorescence (IF) and western blot analysis were used. Statistical analysis showed strong positive correlation between expression of MCM2, MCM3, MCM7 and Ki-67 antigen in LSCC. Additionally, moderate positive correlation was observed between MCM3 and MT-I/II expression. In cancer cells, the level of expression of MCM3, MCM2, MCM7 and Ki-67 markers was increasing with the grade of LSCC malignancy. IF and western blot analysis showed higher MCM2, MCM3, MCM7 expression in HEp-2 cells in comparison to their expression in keratinocytes. MCM proteins might be useful markers of cell proliferation in LSCC.

References

1 

Rodrigo JP, García-Carracedo D, González MV, Mancebo G, Fresno MF and García-Pedrero J: Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas. Mol Cancer. 48:1–9. 2010.

2 

Galli J, Cammarota G, Calò L, Agostino S, D'Ugo D, Cianci R and Almadori G: The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope. 112:1861–1865. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, Gupta PC, Hackshaw A, Matos E, Samet J, Sitas F, Smith J, Stayner L, Straif K, Thun MJ, Wichmann HE, Wu AH, Zaridze D, Peto R and Doll R: Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 96:99–106. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Rudnai P and Brennan P: Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol. 165:814–820. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Hapner ER and Wise JC: Results of a large-scale head and neck cancer screening of an at-risk population. J Voice. 25:480–483. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Islami F, Tramacere I, Rota M, Bagnardi V, Fedirko V, Scotti L, Garavello W, Jenab M, Corrao G, Straif K, Negri E, Boffetta P and La Vecchia C: Alcohol drinking and laryngeal cancer: overall and dose-risk relation - a systematic review and meta-analysis. Oral Oncol. 46:802–810. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Morshed K: Association between human papillomavirus infection and laryngeal squamous cell carcinoma. J Med Virol. 82:1017–1023. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Lewin JS and Gillenwater AM: Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer. 97:1010–1014. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Sereg-Bahar M, Jerin A and Hocevar-Boltezar I: Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer. Radiol Oncol. 49:59–64. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Sapkota A, Hsu CC, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Rudnai P, Janout V, Holcatova I, Brennan P, Boffetta P and Hashibe M: Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control. 19:1161–1170. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE and Kim JW: Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res. 10:8386–8395. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Whitfield ML, George LK, Grant GD and Perou CM: Common markers of proliferation. Nat Rev Cancer. 6:99–106. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Blow JJ and Gillespie PJ: Replication licensing and cancer--a fatal entanglement? Nat Rev Cancer. 8:799–806. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Bedkowska GE, Ławicki S and Szmitkowski M: Molecular markers of carcinogenesis in the diagnostics of cervical cancer. Postepy Hig Med Dosw (Online). 63:99–105. 2009.(in Polish).

15 

Giaginis C, Vgenopoulou S, Vielh P and Theocharis S: MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol. 25:351–370. 2010.PubMed/NCBI

16 

Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS and Nevins JR: E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120–2130. 1998. View Article : Google Scholar : PubMed/NCBI

17 

Nowińska K and Dzięgiel P: The role of MCM proteins in cell proliferation and tumorigenesis. Postepy Hig Med Dosw (Online). 64:627–635. 2010.(in Polish).

18 

Maiorano D, Lutzmann M and Méchali M: MCM proteins and DNA replication. Curr Opin Cell Biol. 18:130–136. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Tye BK and Sawyer S: The hexameric eukaryotic MCM helicase: Building symmetry from nonidentical parts. J Biol Chem. 275:34833–34836. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Tsuji T, Ficarro SB and Jiang W: Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells. Mol Biol Cell. 17:4459–4472. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Honeycutt KA, Chen Z, Koster MI, Miers M, Nuchtern J, Hicks J, Roop DR and Shohet JM: Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene. 25:4027–4032. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Aparicio T, Guillou E, Coloma J, Montoya G and Méndez J: The human GINS complex associates with Cdc45 and MCM and is essential for DNA replication. Nucleic Acids Res. 37:2087–2095. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Moyer SE, Lewis PW and Botchan MR: Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc Natl Acad Sci USA. 103:10236–10241. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 133:1710–1715. 1984.PubMed/NCBI

25 

Czyzewska J, Guzińska-Ustymowicz K, Pryczynicz A, Kemona A and Bandurski R: Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer. Folia Histochem Cytobiol. 47:289–296. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Sarafoleanu D, Postelnicu V, Iosif C, Manea C and Sarafoleanu C: The role of p53, PCNA and Ki-67 as outcome predictors in the treatment of laryngeal cancer. J Med Life. 2:219–226. 2009.

27 

Chatrath P, Scott IS, Morris LS, Davies RJ, Rushbrook SM, Bird K, Vowler SL, Grant JW, Saeed IT, Howard D, et al: Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer. 89:1048–1054. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Mukherjee G, Muralidhar B, Bafna UD, Laskey RA and Coleman N: MCM immunocytochemistry as a first line cervical screening test in developing countries: A prospective cohort study in a regional cancer centre in India. Br J Cancer. 96:1107–1111. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Gambichler T, Bischoff S, Bechara FG, Altmeyer P and Kreuter A: Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J Dermatol Sci. 49:125–132. 2008. View Article : Google Scholar

30 

Tamura T, Shomori K, Haruki T, Nosaka K, Hamamoto Y, Shiomi T, Ryoke K and Ito H: Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: Immunohistochemical study. J Oral Pathol Med. 39:328–334. 2010.PubMed/NCBI

31 

MacCallum DE and Hall PA: The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol. 190:537–544. 2000. View Article : Google Scholar : PubMed/NCBI

32 

Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J and Scholzen T: Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol. 206:624–635. 2006. View Article : Google Scholar

33 

Romero-Isart N, Jensen LT, Zerbe O, Winge DR and Vasak M: Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform metallothionein-1. J Biol Chem. 277:37023–37028. 2002. View Article : Google Scholar : PubMed/NCBI

34 

Ostrakhovitch EA, Olsson PE, von Hofsten J and Cherian MG: P53 mediated regulation of metallothionein transcription in breast cancer cells. J Cell Biochem. 102:1571–1583. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Dziegiel P: Expression of metallothioneins in tumor cells. Pol J Pathol. 55:3–12. 2004.PubMed/NCBI

36 

Werynska B, Pula B, Kobierzycki C, Dziegiel P and Podhorska-Okolow M: Metallothioneins in the lung cancer. Folia Histochem Cytobiol. 53:1–10. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Cherian MG and Kang YJ: Metallothionein and liver cell regeneration. Exp Biol Med. 231:138–144. 2006.

38 

Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E and Zabel M: Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res. 27(1A): 335–342. 2007.PubMed/NCBI

39 

Werynska B, Pula B, Muszczynska-Bernhard B, Piotrowska A, Jethon A, Podhorska-Okolow M, Dziegiel P and Jankowska R: Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer. Anticancer Res. 31:2833–2839. 2011.PubMed/NCBI

40 

Wojnar A, Kobierzycki C, Krolicka A, Pula B, Podhorska-Okolow M and Dziegiel P: Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers. Folia Histochem Cytobiol. 48:442–446. 2010. View Article : Google Scholar : PubMed/NCBI

41 

Sobin LH and Compton CC: TNM seventh edition: What's new, what's changed. Communication from the International Union Against Cancer and the American Joint Committee on Cancer. 22:5336–5339. 2010.

42 

Dziegiel P, Salwa-Zurawska W, Zurawski J, Wojnar A and Zabel M: Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas. Histol Histopathol. 20:83–89. 2005.

43 

Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI

44 

Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI

45 

Gonzalez MA, Tachibana KE, Laskey RA and Coleman N: Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer. 5:135–141. 2005. View Article : Google Scholar : PubMed/NCBI

46 

Rahmanzadeh R, Hüttmann G, Gerdes J and Scholzen T: Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif. 40:422–430. 2007. View Article : Google Scholar : PubMed/NCBI

47 

Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, Jelen M, Matkowski R, Pomiecko A, Spytkowska B, Jagas M, Gisterek I and Kornafel J: Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res. 26(3B): 2473–2478. 2006.PubMed/NCBI

48 

Tokuyasu N, Shomori K, Nishihara K, Kawaguchi H, Fujioka S, Yamaga K, Ikeguchi M and Ito H: Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: Clinicopathological significance. Gastric Cancer. 11:37–46. 2008. View Article : Google Scholar : PubMed/NCBI

49 

Szajerka A, Dziegiel P, Szajerka T, Zabel M, Winowski J and Grzebieniak Z: Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex. Anticancer Res. 28(5B): 2959–2965. 2008.PubMed/NCBI

50 

Padmanabhan V, Callas P, Philips G, Trainer TD and Beatty BG: DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol. 57:1057–1062. 2004. View Article : Google Scholar : PubMed/NCBI

51 

Chatrath P, Scott IS, Morris LS, Davies RJ, Bird K, Vowler SL and Coleman N: Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. Br J Cancer. 95:314–321. 2006. View Article : Google Scholar : PubMed/NCBI

52 

Fletcher RJ, Bishop BE, Leon RP, Sclafani RA, Ogata CM and Chen XS: The structure and function of MCM from archaeal M. Thermoautotrophicum. Nat Struct Biol. 10:160–167. 2003. View Article : Google Scholar : PubMed/NCBI

53 

Forsburg SL: Eukaryotic MCM proteins: Beyond replication initiation. Microbiol Mol Biol Rev. 68:109–131. 2004. View Article : Google Scholar : PubMed/NCBI

54 

Thirumoorthy N, Shyam Sunder A, Manisenthil Kumar K, Senthil Kumar M, Ganesh G and Chatterjee M: A review of metallothionein isoforms and their role in pathophysiology. World J Surg Oncol. 9:542011. View Article : Google Scholar : PubMed/NCBI

55 

Scott IS, Morris LS, Rushbrook SM, Bird K, Vowler SL, Burnet NG and Coleman N: Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: Applications in diagnostic neuropathology. Neuropathol Appl Neurobiol. 31:455–466. 2005. View Article : Google Scholar : PubMed/NCBI

56 

Guida T, Salvatore G, Faviana P, Giannini R, Garcia-Rostan G, Provitera L, Basolo F, Fusco A, Carlomagno F and Santoro M: Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma. J Clin Endocrinol Metab. 90:4703–4709. 2005. View Article : Google Scholar : PubMed/NCBI

57 

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH and McMillan A: Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World J Surg. 30:767–774. 2006. View Article : Google Scholar : PubMed/NCBI

58 

Dudderidge TJ, McCracken SR, Loddo M, Fanshawe TR, Kelly JD, Neal DE, Leung HY, Williams GH and Stoeber K: Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. Br J Cancer. 96:1384–1393. 2007.PubMed/NCBI

59 

Nishihara K, Shomori K, Tamura T, Fujioka S, Ogawa T and Ito H: Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance. Oncol Rep. 21:1189–1195. 2009.PubMed/NCBI

60 

Nowak M, Madej JA and Dziegiel P: Correlation between MCM-3 protein expression and grade of malignancy in mammary adenocarcinomas and soft tissue fibrosarcomas in dogs. In Vivo. 23:49–53. 2009.PubMed/NCBI

61 

Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, et al: Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. Exp Mol Pathol. 88:138–142. 2010. View Article : Google Scholar

62 

Rodrigues RB, Motta RR, Machado SM, Cambruzzi E, Zettler EW, Zettler CG and Jotz GP: Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx. Rev Bras Otorrinolaringol (Engl Ed). 74:855–859. 2008. View Article : Google Scholar

63 

Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G and Sastre-Garau X: Metallothionein expression in mobile tongue squamous cell carcinoma: Associations with clinicopathological parameters and patient survival. Histopathology. 59:514–525. 2011. View Article : Google Scholar : PubMed/NCBI

64 

Arriaga JM, Bravo IA, Bruno L, Morales Bayo S, Hannois A, Sanchez Loria F, Pairola F, Huertas E, Roberti MP, Rocca YS, et al: Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer. Hum Pathol. 43:1695–1703. 2012. View Article : Google Scholar : PubMed/NCBI

65 

Bukholm IR, Bukholm G, Holm R and Nesland JM: Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas. J Clin Pathol. 56:368–373. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

February 2016
Volume 48 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nowinska, K., Chmielewska, M., Piotrowska, A., Pula, B., Pastuszewski, W., Krecicki, T. ... Dziegiel, P. (2016). Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer. International Journal of Oncology, 48, 635-645. https://doi.org/10.3892/ijo.2015.3273
MLA
Nowinska, K., Chmielewska, M., Piotrowska, A., Pula, B., Pastuszewski, W., Krecicki, T., Podhorska-Okołow, M., Zabel, M., Dziegiel, P."Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer". International Journal of Oncology 48.2 (2016): 635-645.
Chicago
Nowinska, K., Chmielewska, M., Piotrowska, A., Pula, B., Pastuszewski, W., Krecicki, T., Podhorska-Okołow, M., Zabel, M., Dziegiel, P."Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer". International Journal of Oncology 48, no. 2 (2016): 635-645. https://doi.org/10.3892/ijo.2015.3273